Haemonetics HAE
NYSE HAE
$105.48 -0.32 (-0.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Haemonetics (HAE) Research & Development (2009 - 2026)

Updated

Haemonetics' Research & Development was $16.2 million in fiscal Q1 2027 (quarter ended Jun 27, 2026), down 0.4% from $16.26 million a year earlier but up 12.1% from the prior quarter.

Analysis

Haemonetics (HAE) Research & Development (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Haemonetics' Research & Development was $59.71 million through Jun 27, 2026, down 7.5% year-over-year; for FY2026 (ended Mar 28, 2026), it was $59.77 million, down 4.7% from FY2025.

  • Research & Development shows a five-year compound annual growth rate of 12.7% (FY2021 to FY2026).
  • In earlier fiscal years, Research & Development was $62.72 million in FY2025 (+15.2%), $54.44 million in FY2024 (+8.6%), $50.13 million in FY2023 (+7.1%) and $46.8 million in FY2022 (+42.4%).
  • Quarterly Research & Development has moved between $10.04 million (fiscal Q3 2022) and $18.31 million (fiscal Q4 2025) over five years.
  • Compared with a year earlier, Research & Development has declined for three straight quarters, with growth averaging 4.0% over the last eight quarters.
  • The best year-over-year quarter for Research & Development over five years was fiscal Q2 2022 (growth of 60.5%); the worst was fiscal Q4 2026 (a decline of 21.1%).
  • Per Business Quant data, HAE's Research & Development in the three fiscal quarters before Q1 2027 was $14.45 million (Q4 2026), $14.19 million (Q3 2026) and $14.87 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 892.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 370.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 771.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 258.00 Mn
10 Haemonetics 4.81 Bn 3.69 Bn 202.80 Mn 16.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 16.20 Mn
Mar 28, 2026 14.45 Mn
Dec 27, 2025 14.19 Mn
Sep 27, 2025 14.87 Mn
Jun 28, 2025 16.26 Mn
Mar 29, 2025 18.31 Mn
Dec 28, 2024 15.83 Mn
Sep 28, 2024 14.14 Mn
Jun 29, 2024 14.45 Mn
Mar 30, 2024 15.86 Mn
Dec 30, 2023 13.27 Mn
Sep 30, 2023 12.67 Mn
Jul 1, 2023 12.65 Mn
Apr 1, 2023 15.64 Mn
Dec 31, 2022 12.69 Mn
Oct 1, 2022 10.90 Mn
Jul 2, 2022 10.90 Mn
Apr 2, 2022 13.21 Mn
Jan 1, 2022 10.04 Mn
Oct 2, 2021 10.85 Mn
API Access

Haemonetics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=HAE&period=max&api_key=YOUR_API_KEY